封面
市場調查報告書
商品編碼
2050918

即時診斷市場:按技術、應用、最終用戶和地區分類

Point of Care Diagnostics Market, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 148 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,即時診斷市場規模將達到 51.3 億美元,到 2033 年將達到 80.2 億美元。預計從 2026 年到 2033 年,該市場將以 6.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 51.3億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.60% 2033年市場規模預測: 820億美元

即時診斷(POC)是指在檢查室之外,在患者接受治療的場所附近或現場進行的醫學診斷測試。傳統上,大多數診斷測試都在中心檢查室進行。然而,即時診斷無需將檢體運送到遙遠的檢查室,即可實現更快的檢測結果、更迅速的臨床決策和即時治療。技術進步使得開發攜帶式、方便用戶使用的設備成為可能,這些設備適用於以患者為中心的各種環境,例如診所、急診室、藥房和家庭。對快速檢測和分散式醫療保健日益成長的需求、感染疾病率的上升以及易患慢性病的老年人口的成長,都可能推動全球即時診斷市場的成長。

市場動態

全球即時診斷市場成長的促進因素包括:對快速、便利、即時檢測結果的需求不斷成長;慢性病和感染疾病的盛行率上升;全球人口老化;以及推動方便用戶使用型攜帶式即時診斷設備發展的技術進步。然而,開發中國家基礎設施和專業技術人員的匱乏、先進即時診斷設備的高成本以及部分設備檢測結果的不可靠性可能會阻礙市場成長。此外,新興市場尚未開發的市場機會、人工智慧和物聯網等先進技術與即時診斷設備的融合,以及即時診斷檢測在居家醫療日益廣泛的應用,都可能為市場相關人員帶來巨大的商機。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球照護現場診斷市場主要公司的概況:公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球即時診斷市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用各種用於分析全球即時診斷市場的策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球即時診斷市場:依技術分類,2021-2033年

  • 側向流
  • 凝血法
  • 流通式
  • 固相
  • 生物感測器

第5章 全球即時診斷市場:依應用領域分類,2021-2033年

  • 心血管和代謝檢查
  • 傳染病檢查
  • 腎臟檢查
  • 藥物濫用(DoA)檢測
  • 血糖值測量
  • 妊娠測試
  • 癌症生物標記檢測
  • 其他

第6章 全球即時診斷市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷檢查室
  • 居家醫療
  • 其他

第7章 全球即時診斷市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Qiagen Inc.
  • Johnson & Johnson Services, Inc.
  • Danaher Corporation(Beckman Coulter Inc.)
  • Instrumentation Laboratory
  • Nova Biomedical Corporation
  • Biomeriux SA
  • GE Healthcare
  • Philips Healthcare
  • Quest Diagnostics
  • Fujifilm Medical
  • Thermo Fisher Scientific
  • Hologic
  • Canon
  • IDEXX Laboratories
  • Sysmex
  • QuidelOrtho

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1515

Point Of Care Diagnostics Market is estimated to be valued at USD 5.13 Bn in 2026 and is expected to reach USD 8.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.13 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.60% 2033 Value Projection: USD 8.02 Bn

Point of care (POC) diagnostics refers to medical diagnostic testing performed outside a laboratory, near or at the site of patient care. Traditionally, most diagnostic tests were conducted in centralized laboratories. However, POC diagnostics helps deliver faster results, enable quick clinical decisions, and provide treatment immediately without transferring samples to distant labs. Technological advancements have enabled the development of portable and easy-to-use devices suitable for near-patient settings like doctor's offices, emergency rooms, pharmacies, and homes. Rising demand for rapid testing and decentralized healthcare, increasing incidence of infectious diseases and growing elderly population susceptible to chronic conditions can drive the global point of care diagnostics market growth.

Market Dynamics

Global point of care diagnostics market growth is driven by factors like growing demand for rapid, convenient and real-time test results, increasing prevalence of chronic and infectious diseases, rising geriatric population worldwide, technological advancements leading to development of user-friendly and portable POC devices. However, lack of infrastructure and skilled professionals in developing nations, high cost of advanced POC devices, and unreliable test results associated with some devices can hamper the market growth. Moreover, untapped opportunities in emerging markets, integration of advanced technologies like AI and IoT with POC devices, and growing applications of POC testing in home healthcare can offer significant opportunities for the market players.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global point of care diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global point of care diagnostics market

Market Segmentation

  • By Technology Insights (Revenue, USD Bn, 2026 - 2033)
  • Lateral Flow
  • Agglutination Assays
  • Flow-Through
  • Solid Phase
  • Biosensors
  • By Application Insights (Revenue, USD Bn, 2026 - 2033)
  • Cardio Metabolic Testing
  • Infectious Disease Testing
  • Nephrology Testing
  • Drugs of Abuse (DoA) Testing
  • Blood Glucose Testing
  • Pregnancy Testing
  • Cancer Biomarker Testing
  • Others
  • By End User Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Home-Care Settings
  • Others
  • By Regional Insights (Revenue, USD Bn, 2026 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Qiagen Inc.
  • Johnson & Johnson Services, Inc.
  • Danaher Corporation (Beckman Coulter Inc.)
  • Instrumentation Laboratory
  • Nova Biomedical Corporation
  • Biomeriux SA
  • GE Healthcare
  • Philips Healthcare
  • Quest Diagnostics
  • Fujifilm Medical
  • Thermo Fisher Scientific
  • Hologic
  • Canon
  • IDEXX Laboratories
  • Sysmex
  • QuidelOrtho

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Point of Care Diagnostics Market, By Technology
    • Global Point of Care Diagnostics Market, By Application
    • Global Point of Care Diagnostics Market, By End User
    • Global Point of Care Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Point of Care Diagnostics Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Lateral Flow
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Agglutination Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Flow-Through
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Solid Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Point of Care Diagnostics Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardio Metabolic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Infectious Disease Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Nephrology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Drugs of Abuse (DoA) Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Blood Glucose Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pregnancy Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cancer Biomarker Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Point of Care Diagnostics Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Home-Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Point of Care Diagnostics Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qiagen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Beckman Coulter Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Instrumentation Laboratory
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nova Biomedical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biomeriux SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sysmex
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QuidelOrtho
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us